Publications by authors named "Jacques Schipper"

Claim this Profile
T
The selective glycine uptake inhibitor org 25935 as an adjunctive treatment to atypical antipsychotics in predominant persistent negative symptoms of schizophrenia: results from the GIANT trial.
Joep H Schoemaker, Wim T Jansen, Jacques Schipper, Armin Szegedi

J Clin Psychopharmacol· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A translational approach to evaluate the efficacy and safety of the novel AMPA receptor positive allosteric modulator org 26576 in adult attention-deficit/hyperactivity disorder.
Lenard A Adler, René A Kroon, Mark Stein, Mohammed Shahid, Frank I Tarazi, Jacques Schipper

Biol Psychiatry· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Examination of Org 26576, an AMPA receptor positive allosteric modulator, in patients diagnosed with major depressive disorder: an exploratory, randomized, double-blind, placebo-controlled trial.
Kari R Nations, Peter Dogterom, Roberta Bursi, Jacques Schipper, Scott Greenwald

J Psychopharmacol· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Maximum tolerated dose evaluation of the AMPA modulator Org 26576 in healthy volunteers and depressed patients: a summary and method analysis of bridging research in support of phase II dose selection.
Kari R Nations, Roberta Bursi, Peter Dogterom, Larry Ereshefsky, Lev Gertsik, Jacques Schipper

Drugs R D· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the glycine transporter inhibitor Org 25935 as augmentation to cognitive-behavioral therapy for panic disorder: a multicenter, randomized, double-blind, placebo-controlled trial.
Kari R Nations, Jasper A J Smits, David F Tolin, Barbara O Rothbaum, Stefan G Hofmann, Jacques Schipper

J Clin Psychiatry· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glycine transporter inhibitor attenuates the psychotomimetic effects of ketamine in healthy males: preliminary evidence.
Deepak Cyril D'Souza, Nagendra Singh, Jacqueline Elander, Michelle Carbuto, Brian Pittman, Jacques Schipper

Neuropsychopharmacology· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Translational PK-PD modelling of molecular target modulation for the AMPA receptor positive allosteric modulator Org 26576.
Roberta Bursi, Gul Erdemli, Robert Campbell, Matthew M Hutmacher, Thomas Kerbusch, Jacques Schipper

Psychopharmacology (Berl)· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis